mrd using multi-parametric flow cytometry in al amyloidosis
Published 3 years ago • 86 plays • Length 4:10Download video MP4
Download video MP3
Similar videos
-
1:53
the prognostic role of mrd in al amyloidosis
-
1:43
the value of using next-generation flow cytometry to measure mrd status
-
0:41
mrd measurement: next-generation sequencing or flow cytometry?
-
2:04
mrd assessment: ngs vs. flow cytometry
-
3:05
mrd negativity assessed by flow cytometry associated with improved outcomes in npm1-mutated aml
-
1:49
using flow cytometry to detect abnormal plasma cells in mgus & predict disease progression
-
2:13
advances & unanswered questions about the role of mrd in al amyloidosis
-
3:00
mrd as a prognostic tool in amyloidosis
-
1:45
role for mrd assessment in al amyloidosis?
-
1:13
cytometry versus morphology in the monitoring of aml
-
1:52
mrd by flow cytometry
-
1:36
the importance of mrd as a prognostic tool in multiple myeloma
-
2:32
flow cytometry vs. molecular methods for mrd testing in acute leukemias
-
2:23
the use of immunophenotyping to assess minimal residual disease (mrd) in multiple myeloma
-
1:56
ngs vs flow cytometry for mrd assessment in npm1-mutated aml
-
1:19
al amyloidosis: mrd negativity
-
1:32
methods to evaluate mrd in aml
-
2:02
measuring mrd: methods and challenges
-
2:11
ngs vs. flow cytometry for mrd in mm